What podcasts say about CSL
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about CSL
11 statements · 9 positive · 2 negative
CSL is an industry-leading business in blood plasma and vaccines.
“It's a wonderful business, blood plasma vaccines, all that sort of stuff. It's an industry leader.”
Open the episode · Rates rise around the world, why the Aged Pension isn't enough & Pimp my Portfolio with Owen RaskListen at 31:42
CSL staged a major rally after becoming deeply undervalued.
“We were maximum CSL across all our funds. And since then, it's had this astonishing rally.”
Open the episode · Riding the rebound in CSL, Cochlear and finding the next opportunityListen at 14:00
CSL shares rose 38% in one month after its reporting result.
“the stock just, you know, it was up 38% in a month.”
Open the episode · Hofflin: Big moves are creating great value on the ASXListen at 14:14
CSL’s 38% rally was justified because the stock had been substantially underpriced.
“I think it was justified in the sense that the stock was just so underpriced.”
Open the episode · Hofflin: Big moves are creating great value on the ASXListen at 14:27
CSL’s relief rally was justified because the stock had been underpriced.
“I think it was justified in the sense that the stock was just so underpriced.”
Open the episode · Riding the rebound in CSL, Cochlear and finding the next opportunityListen at 14:27
CSL was recently considered very cheap by Hofflin.
“In principle, two or three months ago I would have said, easy, CSL, right? This is so cheap.”
Open the episode · Hofflin: Big moves are creating great value on the ASXListen at 38:17
CSL’s annual profit fell 2%.
“2% fall in annual profit”
Open the episode · Data centre resistance grows, CSL is (sort of) back & a stock picker joins Pimp my PortfolioListen at 17:42
CSL could recover after its temporary earnings setback.
“This CSL could be a similar story.”
Open the episode · Data centre resistance grows, CSL is (sort of) back & a stock picker joins Pimp my PortfolioListen at 18:55
CSL shares rose 18% amid touted new drug developments.
“CSL is up 18% as they tout some new drug developments.”
Open the episode · BHP Rises, Tokyo Electron Down, Alibaba UpListen at 1:10
CSL shares rose 18% amid new drug developments and a planned reset quarter.
“CSL is up 18% as they tout some new drug developments and plan a reset quarter as they call it.”
Open the episode · BHP Rises, Tokyo Electron Down, Alibaba UpListen at 1:25
CSL remains substantially below its near-300 peak price.
“it's still considerably down from its sort of near 300 peak.”
Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael BurryListen at 13:12
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.